Khalil Ahmad S, Khedr Marwa A M, Gad Ahmed A M, Ali Ali Goda
J Refract Surg. 2025 May;41(5):e492-e500. doi: 10.3928/1081597X-20250409-01. Epub 2025 May 1.
To evaluate the efficacy and safety of accelerated corneal cross-linking (A-CXL) while preserving the epithelium over the central 3 mm of the cornea compared to epithelium removal CXL in cases of paracentral keratoconus.
In this prospective comparative study, 140 eyes of 77 patients were randomized to receive either A-CXL with preservation of the central 3 mm of corneal epithelium or A-CXL with removal of whole corneal epithelium over a central disk area with a diameter of 9 mm. Patients were observed regularly for 1 year after the procedure. The primary outcome measures were to compare early uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA), corneal haze, pain, and discomfort in the first week between the two groups. The secondary outcome measure was keratoconus progression after 12 months of follow-up, measured by the maximum keratometry (Kmax) value.
A significant difference was found between the two groups regarding early postoperative CDVA, corneal haze, pain, and discomfort, with more favorable results in the ACXL with preservation of the central 3 mm of corneal epithelium group. At 12 months of follow-up, a significant improvement in UDVA, CDVA, and Kmax was noticed among patients of the same group, with better final vision and a reduction in Kmax as compared to the preoperative values.
Preserving the epithelium over the central 3 mm of the cornea during A-CXL in cases with paracentral keratoconus can provide the benefits of immediate early postoperative visual rehabilitation, less corneal haze, less pain, good efficacy, and prevention of keratoconus progression. .
评估在周边圆锥角膜病例中,与去除上皮的角膜交联术(CXL)相比,保留角膜中央3mm上皮的加速角膜交联术(A-CXL)的疗效和安全性。
在这项前瞻性对照研究中,77例患者的140只眼睛被随机分为两组,一组接受保留角膜中央3mm上皮的A-CXL,另一组接受去除直径9mm中央盘状区域全层角膜上皮的A-CXL。术后对患者进行为期1年的定期观察。主要观察指标是比较两组术后第一周的早期未矫正远视力(UDVA)、矫正远视力(CDVA)、角膜混浊、疼痛和不适情况。次要观察指标是随访12个月后圆锥角膜的进展情况,通过最大角膜曲率(Kmax)值来衡量。
两组在术后早期的CDVA、角膜混浊、疼痛和不适方面存在显著差异,保留角膜中央3mm上皮的A-CXL组效果更佳。随访12个月时,同一组患者的UDVA、CDVA和Kmax均有显著改善,与术前相比,最终视力更好,Kmax降低。
在周边圆锥角膜病例的A-CXL过程中保留角膜中央3mm的上皮,可以带来术后早期视力即刻恢复、角膜混浊减轻、疼痛减轻、疗效良好以及预防圆锥角膜进展等益处。